Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 26, 2020
Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization
Xiao-Lu Ma, Xu-Dong Qu, Wen-Jing Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection
Xin-Rong Yang, Yang Xu, Guo-Ming Shi, et al.
The Lancet. Oncology
|
June 29, 2012
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
Qiujin Shen, Jia Fan, Xin-Rong Yang, et al.
Cancer Letters
|
June 6, 2026
Multi-Omic Profiling Identifies TREM2<sup>+</sup> Lipid-laden Macrophages as Inflammatory Drivers and Therapeutic Targets of Colorectal Cancer Liver Metastasis
Peng-Xiang Wang, Yu-Chen Zhong, Wen-Jing Zheng, et al.
Journal of Cancer Research and Clinical Oncology
|
May 13, 2008
Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials
Guo-Ming Shi, Yang Xu, Jia Fan, et al.
Clinical and Translational Medicine
|
May 14, 2024
Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study
De-Zhen Guo, Ao Huang, Ying-Chao Wang, et al.
Hepatology International
|
November 18, 2023
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer
Ao Huang, De-Zhen Guo, Xuan Zhang, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma
Fei Song, Yi-Jun Lu, Hai-Xiang Sun, et al.
Nature Communications
|
November 17, 2025
Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation
Sui-Yi Wu, Yuan-Yuan Zhu, Jia-Lei Sun, et al.
Plos One
|
October 15, 2011
Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation
Jie Hu, Zheng Wang, Jia Fan, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 26, 2020
Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization
Xiao-Lu Ma, Xu-Dong Qu, Wen-Jing Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection
Xin-Rong Yang, Yang Xu, Guo-Ming Shi, et al.
The Lancet. Oncology
|
June 29, 2012
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
Qiujin Shen, Jia Fan, Xin-Rong Yang, et al.
Cancer Letters
|
June 6, 2026
Multi-Omic Profiling Identifies TREM2<sup>+</sup> Lipid-laden Macrophages as Inflammatory Drivers and Therapeutic Targets of Colorectal Cancer Liver Metastasis
Peng-Xiang Wang, Yu-Chen Zhong, Wen-Jing Zheng, et al.
Journal of Cancer Research and Clinical Oncology
|
May 13, 2008
Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials
Guo-Ming Shi, Yang Xu, Jia Fan, et al.
Clinical and Translational Medicine
|
May 14, 2024
Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study
De-Zhen Guo, Ao Huang, Ying-Chao Wang, et al.
Hepatology International
|
November 18, 2023
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer
Ao Huang, De-Zhen Guo, Xuan Zhang, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma
Fei Song, Yi-Jun Lu, Hai-Xiang Sun, et al.
Nature Communications
|
November 17, 2025
Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation
Sui-Yi Wu, Yuan-Yuan Zhu, Jia-Lei Sun, et al.
Plos One
|
October 15, 2011
Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation
Jie Hu, Zheng Wang, Jia Fan, et al.
Page
of 12